Unresectable Melanoma
Showing 26 - 46 of 46
Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)
Available
- Unresectable Melanoma
- Metastatic Melanoma
- Lifileucel
-
Orlando, Florida
- +2 more
Jul 19, 2022
NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated
Recruiting
- NSCLC Stage IV
- +3 more
- Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022
Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab
Recruiting
- Unresectable Melanoma
- +3 more
- Sargramostim (GM-CSF)
- Pembrolizumab (anti-PD-1)
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- +7 more
- Binimetinib
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +3 more
- Ipilimumab
- Nivolumab
-
Rochester, MinnesotaMayo Clinic in Rochester
May 6, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States
Active, not recruiting
- Stage IIIC Cutaneous Melanoma AJCC v7
- +2 more
- Bevacizumab
- Ipilimumab
-
Birmingham, Alabama
- +488 more
Mar 19, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in France, United States (Nivolumab, Ipilimumab, Placebo)
Completed
- Unresectable Melanoma
- Metastatic Melanoma
- Nivolumab
- +2 more
-
San Francisco, California
- +20 more
Feb 16, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in Poland, Spain (APX005M)
Active, not recruiting
- Unresectable Melanoma
- Metastatic Melanoma
-
Warsaw, Poland
- +12 more
Mar 8, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib Mesylate
- +3 more
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine
Dec 29, 2021
Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)
Active, not recruiting
- Melanoma
- +3 more
- Binimetinib Oral Tablet
-
Rennes, FranceBiotrial
Nov 30, 2021
BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma Trial in Czechia, Italy, Spain (Encorafenib + Binimetinib)
Not yet recruiting
- BRAF V600 Mutation
- +3 more
- Encorafenib + Binimetinib
-
Olomouc, Czechia
- +5 more
Sep 14, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +38 more
- Pembrolizumab
- Sonidegib
-
Scottsdale, Arizona
- +2 more
Aug 27, 2021
Melanoma Stage IV, Unresectable Melanoma, NSCLC Stage IV Trial in Ramat Gan (Fecal Microbial Transplantation by capsules)
Recruiting
- Melanoma Stage IV
- +2 more
- Fecal Microbial Transplantation by capsules
-
Ramat Gan, IsraelSheba Medical Center
Aug 9, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Dietary Intervention
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 22, 2021
Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor
Completed
- Stage III Melanoma
- +3 more
- BRAF inhibitor dabrafenib and MEK inhibitor trametinib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center, University of North Caro
Nov 3, 2020
Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,
Completed
- Metastatic Melanoma
- +4 more
- Bevacizumab
- +4 more
-
San Francisco, California
- +12 more
Jan 7, 2020
Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Orange (Pazopanib and Paclitaxel)
Completed
- Stage III Melanoma
- +2 more
- Pazopanib and Paclitaxel
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Aug 5, 2019
Unresectable Melanoma Trial in Durham (Ipilimumab)
Completed
- Unresectable Melanoma
-
Durham, North CarolinaDuke University Medical Center
Oct 26, 2018